Verrica Pharmaceuticals goes public
West Chester, Pennsylvania-based Verrica Pharmaceuticals, a developer of products that treat skin diseases, has raised $75 million for its IPO after pricing its 5 million share at $15 per share. The stock began trading June 15, 2018 on the NASDAQ under the ticker symbol "VRCA." BofA Merrill Lynch, Jefferies and Cowen are the lead underwriters. Verrica's pre-IPO backers include PBM Capital Group and OrbiMed.
15 June 2018•2 mins read
